cas: 2296729-00-3 — see every product listed under this CAS number, including other names
Sotorasib, 99.90% (CAS 2296729-00-3) is a chemical reagent available from Chemat. Available pack sizes: 10mM/1mL, 100 mg, 25 mg, 2 mg, 5 mg, 10 mg, 500 mg, 1 g. Offered by: MedChemExpress.
| brand | MedChemExpress |
|---|---|
| catalog number | HY-114277-10mM/1mL |
| cas | 2296729-00-3 |
| size | 10mM/1mL |
| availability | In stock |
Ask us about this product — we're happy to help.
| brand | size | price | |
|---|---|---|---|
| MedChemExpress | 10mM/1mL | 654.06 Pln | |
| MedChemExpress | 100 mg | 2999.28 Pln | |
| MedChemExpress | 25 mg | 1536.42 Pln | |
| MedChemExpress | 2 mg | 384.71 Pln | |
| MedChemExpress | 5 mg | 551.89 Pln | |
| MedChemExpress | 10 mg | 886.26 Pln | |
| MedChemExpress | 500 mg | 6259.37 Pln | |
| MedChemExpress | 1 g | 8516.35 Pln | |
| MedChemExpress | 50 mg | 2423.42 Pln |
| delivery time | 1-2 weeks |
|---|---|
| purity | 99.90% |
Sotorasib is a pyridopyrimidine that is pyrido[2,3-d]pyrimidin-2(1H)-one substituted by 4-methyl-2-(propan-2-yl)pyridin-3-yl, (2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl, fluoro and 2-fluoro-6-hydroxyphenyl groups at positions 1, 4, 6 and 7, respectively. It is approved for the treatment of patients with non-small cell lung cancer having KRASG12C mutations. It has a role as an antineoplastic agent. It is a tertiary carboxamide, a member of acrylamides, a member of methylpyridines, a member of phenols, a pyridopyrimidine, a N-acylpiperazine, a tertiary amino compound and a member of monofluorobenzenes.
Source: ChEBI
| Molecular formula | C30H30F2N6O3 |
|---|---|
| Molecular weight | 560.6 g/mol |
| IUPAC name | 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-yl-3-pyridinyl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one |
| InChIKey | NXQKSXLFSAEQCZ-SFHVURJKSA-N |
| SMILES | C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C |
Computed by PubChem (NCBI)